Literature DB >> 414779

Structural elucidation of the 3-deoxy-D-manno-octulosonic acid containing meningococcal 29-e capsular polysaccharide antigen using carbon-13 nuclear magnetic resonance.

A K Bhattacharjee, H J Jennings, C P Kenny.   

Abstract

The capsular polysaccharide antigen from Neisseria meningitidis serogroup 29-e contains equimolar quantities of 2-acetamido-2-deoxy-D-galactose and 3-deoxy-D-manno-octulosonic acid (KDO), the latter of which is rarely found in biopolymers other than lipopolysaccharides. Carbon-13 nuclear mangetic resonance in conjunction with other chemical data indicated that the polysaccharide is composed of an alternating sequence of these two residues, the linkages being at C-3 of galactosamine and C-7 of KDO in the alpha-D and beta-D configuration, respectively. The native 29-e polysaccharide is O-acetylated, the O-acetyl groups being located at C-4 and C-5 of the KDO residues. Assignments of signals in the 13C nuclear magnetic resonance spectrum of the 29-e polysaccharide were made by consideration of those in the spectra of the monomer models, which necessitated the first recorded syntheses of methyl-alpha- and beta-D-3-deoxy-manno-octulopyranosonic acid. Like the methyl alpha- and beta-D-ketosides of sialic acid (Na+ salts), the equivalent methyl alpha- and beta-D-ketosides of KDO exhibit large chemical shift differences in the exocyclic C-8 position dependent on anomeric configuration. This can again be attributed to hydrogen bonding between the axial carboxylate group of the methyl beta-D anomer of KDO (C1 conformation) and the primary hydroxyl group at C-8. This phenomenon is also exhibited by the beta-D-linked KDO units of the 29-e polysaccharide.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 414779     DOI: 10.1021/bi00597a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  Characterization of the capsular polysaccharide of Burkholderia (Pseudomonas) pseudomallei 304b.

Authors:  H Masoud; M Ho; T Schollaardt; M B Perry
Journal:  J Bacteriol       Date:  1997-09       Impact factor: 3.490

Review 2.  The meningococcus and mechanisms of pathogenicity.

Authors:  I W DeVoe
Journal:  Microbiol Rev       Date:  1982-06

3.  Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation.

Authors:  Peter C Fusco; Esmé K Farley; Chun-Hsien Huang; Samuel Moore; Francis Michon
Journal:  Clin Vaccine Immunol       Date:  2007-03-21

4.  Structure and serological specificity of the K13-antigenic polysaccharide (K13 antigen) of urinary tract-infective Escherichia coli.

Authors:  W F Vann; K Jann
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

5.  Structure, serological specificity, and synthesis of artificial glycoconjugates representing the genus-specific lipopolysaccharide epitope of Chlamydia spp.

Authors:  O Holst; L Brade; P Kosma; H Brade
Journal:  J Bacteriol       Date:  1991-03       Impact factor: 3.490

6.  Immunologically related ketodeoxyoctonate-containing structures in Chlamydia trachomatis, Re mutants of Salmonella species, and Acinetobacter calcoaceticus var. anitratus.

Authors:  M Nurminen; E Wahlström; M Kleemola; M Leinonen; P Saikku; P H Mäkelä
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

7.  Purification and characterization of polyphosphate kinase from Neisseria meningitidis.

Authors:  C R Tinsley; B N Manjula; E C Gotschlich
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Serological, chemical, and structural analyses of the Escherichia coli cross-reactive capsular polysaccharides K13, K20, and K23.

Authors:  W F Vann; T Soderstrom; W Egan; F P Tsui; R Schneerson; I Orskov; F Orskov
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  A new serogroup (L) of Neisseria meningitidis.

Authors:  F E Ashton; A Ryan; B Diena; H J Jennings
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

10.  Safety and immunogenicity of a group 29E meningococcal capsular polysaccharide vaccine in adults.

Authors:  J M Griffiss; B L Brandt; P L Altieri; G B Pier; S L Berman
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.